Table 2.
Comparison of different rodent models of NAFLD.
| Obesity | Insulin resistance | Steatosis | Fibrosis | NASH | |
|---|---|---|---|---|---|
| Dietary models | |||||
| MCD | No | Hepatic IR only | Yes | Yes | Yes |
| CDAA | No | No | Yes | Yes | Yes |
| HFD | Yes | Yes | Yes | No | No |
| HFHS (inc. fructose/glucose/sucrose) | Yes | Yes | Yes | Some | Some |
| Chemical/pharmacological | |||||
| STZ + HFD | Yes | Yes | Yes | Yes | Yes |
| CCL4 | No | No | Yes | Yes | Yes |
| Paracetamol | No | No | Yes | Yes | Yes |
| Genetic models | |||||
| ob/ob mice | Yes | Yes | Yes | No | No |
| db/db mice | Yes | Yes | Yes | No | No |
| PTEN knockout mice | No | No | Yes | Yes | Yes |
| SREBP-1c transgenic mice | Weight loss | Yes | Yes | Yes | Yes |
| KK-Ay/a mice | Yes | Yes | Yes | No | No |
| PPAR-α knockout mice | No | No | Yes | No | No |
| AOX knockout mice | No | No | Yes | No | Yes (transient) |
| CD36 knockout mice | No | Hepatic IR only | Yes | No | Yes |
| ApoE knockout mice | No | No | Yes | No | No |